Status:
COMPLETED
High-intensity Strength Training in Myositis
Lead Sponsor:
Rigshospitalet, Denmark
Collaborating Sponsors:
University of Southern Denmark
Odense University Hospital
Conditions:
Myositis
Dermatomyositis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study evaluates the effects of a high-intensity strength training in patients with myositis with the primary outcome being quality of life (SF-36). The study is designed as a parallel group rando...
Detailed Description
Overall aim: To investigate the effect of high-intensity strength training on quality of life, muscle strength, physical function, and disease activity in patients with myositis Study design: 60 my...
Eligibility Criteria
Inclusion
- Fulfilling the criteria for myositis by EULAR/ACR (Bottai et al., 2017; Lundberg et al., 2017)
- ≤ 5 mg/day Prednisolone
- Stable dosage of immunosuppressive treatment for at least 1 months prior to inclusion in the study
- Myositis diagnosis at least 6 months prior to inclusion in the study
Exclusion
- Patients with sporadic inclusion body myositis and overlap myositis (myositis combined with another autoimmune rheumatic diseases, except Sjögren's Syndrome)
- Co-morbidity preventing resistance training (severe heart/lung-disease, uncontrolled hypertension (systolic \> 160mmHg, diastolic \> 100mmHg), severe knee/hip arthritis)
- Alcohol- and/or drug abuse. Defined by the guidelines issued by The Danish Health Authority
Key Trial Info
Start Date :
August 30 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2023
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT04486261
Start Date
August 30 2021
End Date
January 1 2023
Last Update
April 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rigshospitalet
Copenhagen, Denmark, 2100